Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-rabies monoclonal antibody in healthy volunteers
NCT07445815Phase 2Not yet recruiting
- Sponsor
- Lanzhou Institute of Biological Products Co., Ltd.
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human anti-rabies virus monoclonal antibody in rabies, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
recombinant human anti-rabies virus monoclonal antibody
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07445815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445815.